𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PSY17 THE COST AND COST EFFECTIVENESS OF DASATINIB (SPRYCEL) THERAPY FOR THE MANAGEMENT OF IMATINIB RESISTANT AND INTOLERANT PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN MEXICO

✍ Scribed by A Juarez-Garcia; L Zapata; G Vega; J Idrovo; R Rivas; JL Kramis; G Litalien; S Rangel


Book ID
118609192
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
68 KB
Volume
11
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES